Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus

Figure 3.
Figure 3. Survival curve showing years to seroconversion to hepatitis B surface antigen (HBsAg) negativity in carriers, by hepatitis B e antigen (HBeAg)/anti-HBe status.

Line patterns represent carriers who seroconverted from HBeAg to anti-HBe; those who seroconverted from HBeAg to anti-HBe, then had reactivation of HBeAg; those who were persistently HBeAg negative and anti-HBe positive; and those who were initially anti-HBe positive, then had reactivation of HBeAg.

This Article

  1. Ann Intern Med November 6, 2001 vol. 135 no. 9 759-768
  1. AbstractFREE
  2. Figures
  3. Full Text
  4. Full Text (PDF)

Current Issue

  1. November 17, 2009, 151 (10)
  1. Alert me to current issues